Ontology highlight
ABSTRACT:
SUBMITTER: Li W
PROVIDER: S-EPMC11252460 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
Li Wenfeng W Chen Shuming S Lang Jing J Luo Jing J Chen Jiahui J Zhang Liping L Sun Zhijie Z Dong Deli D
Acta pharmaceutica Sinica. B 20240328 7
The drugs extending healthspan in clinic have always been searched. Nitazoxanide is an FDA-approved clinical antiprotozoal drug. Nitazoxanide is rapidly metabolized to tizoxanide after absorption <i>in vivo</i>. Our previous studies find that nitazoxanide and its metabolite tizoxanide induce mild mitochondrial uncoupling and activate cellular AMPK, oral nitazoxanide protects against experimental hyperlipidemia, hepatic steatosis, and atherosclerosis. Here, we demonstrate that both nitazoxanide a ...[more]